Shubhangi Shelke 
Introduction to Berdazimer Gel : What Is Berdazimer ? Berdazimer is a topical medication that was approved by the US FDA in 2024 for the treatment of molluscum contagiosum in patients 1 year of age and older. It is formulated at a 10.3% strength and is the first nitric oxide-releasing gel of its kind for …
Introduction : Hereditary angioedema (HAE) is a rare and potentially life-threatening genetic condition characterized by sudden swelling in various parts of the body. Managing acute attacks has long been a challenge, but a new FDA-approved oral treatment is offering hope. Acterly, the first-of-its-kind oral plasma kallikrein inhibitor, is revolutionizing the way patients are treated for …
Introduction : Urinary tract infections (UTIs) are the most common bacterial infections in women. With increasing antibiotic resistance, the medical community urgently needs new, more effective agents. In a major breakthrough, the US FDA approved Blujepa in March 2025 for the treatment of uncomplicated urinary tract infections (uUTIs) in female patients aged 12 years and …
Generic Name : Nipocalimab Brand Name : Imaavy Drug Class : Anti-neonatal Fc receptor (FcRn) monoclonal antibody Dosage form : Injection . Introduction : Autoimmune diseases have long presented challenges in treatment and management. One such condition is myasthenia gravis (MG), a chronic autoimmune neuromuscular disorder that causes weakness in skeletal muscles. In 2024, a …
Brand Name : Vanrafia Generic Name : atrasentan Drug Class : endothelial antagonist Dosage Form : Oral tablets . Introduction : Having too much protein in your urine isn’t just a symptom—it’s a red flag that indicates kidney damage. If left unchecked, proteinuria can lead to chronic kidney disease (CKD) and even end-stage renal failure. …
Brand name: QfitliaGeneric name: fitusiranDosage form: InjectionDrug class : Antithrombin-targeting siRNA Introduction : In March 2025, a historic breakthrough was made in the world of rare diseases – the US FDA officially approved Fitusiran approval for the treatment of hemophilia A and B, with and without inhibitors. The approval was long-awaited due to the drug’s revolutionary RNA interference …
Name of Drug : Penpulimab-kcqx Drug Category : Antineoplastic agent Form : Injection . Introduction : Nasopharyngeal carcinoma (NPC) is a rare cancer that arises in the nasopharynx, most often seen in the non-keratinizing form linked to the Epstein Barr virus. In April 2025, the FDA approved a promising immunotherapy: penpulimab KCQX, a next-generation PD1 …
Generic Name : Acoltremon Brand Name :Tryptyr Drug Class : TRPM8 thermoreceptor agonist Dosage : Ophthalmic Solution 0.003 Introduction: Dry eye disease (DED) affects millions of people worldwide, causing discomfort, blurred vision, and irritation that can impact daily life. Conventional treatments such as artificial tears or steroids often provide temporary relief. Enter acoltremone – a …
Introduction : Lung cancer is one of the most challenging cancers to treat globally. Of its various forms, non-small cell lung cancer (NSCLC) is the most common, with many patients harboring specific genetic alterations such as ROS1 or NTRK fusions. This has opened the door to targeted therapies, and talatrectinib has emerged as a promising …
Introduction : Lung cancer is one of the most challenging cancers to treat, especially in its advanced stages. As scientists and pharmaceutical companies strive for better results, one promising treatment that has garnered attention in recent years is telisotuzumab adizutecan. This antibody-drug conjugate (ADC) is making waves in clinical trials for a targeted approach to …
